GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » iRhythm Technologies Inc (LTS:0A7L) » Definitions » Change In Receivables

iRhythm Technologies (LTS:0A7L) Change In Receivables : $-77.5 Mil (TTM As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is iRhythm Technologies Change In Receivables?

iRhythm Technologies's change in receivables for the quarter that ended in Mar. 2025 was $-30.1 Mil. It means iRhythm Technologies's Accounts Receivable increased by $30.1 Mil from Dec. 2024 to Mar. 2025 .

iRhythm Technologies's change in receivables for the fiscal year that ended in Dec. 2024 was $-91.9 Mil. It means iRhythm Technologies's Accounts Receivable increased by $91.9 Mil from Dec. 2023 to Dec. 2024 .

iRhythm Technologies's Accounts Receivable for the quarter that ended in Mar. 2025 was $80.6 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. iRhythm Technologies's Days Sales Outstanding for the three months ended in Mar. 2025 was 46.37.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. iRhythm Technologies's liquidation value for the three months ended in Mar. 2025 was $-251.2 Mil.


iRhythm Technologies Change In Receivables Historical Data

The historical data trend for iRhythm Technologies's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iRhythm Technologies Change In Receivables Chart

iRhythm Technologies Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -37.96 -53.57 -61.84 -81.19 -91.92

iRhythm Technologies Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -44.52 -15.00 -9.16 -23.24 -30.13

iRhythm Technologies Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-77.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


iRhythm Technologies  (LTS:0A7L) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

iRhythm Technologies's Days Sales Outstanding for the quarter that ended in Mar. 2025 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=80.639/158.677*91
=46.37

2. In Ben Graham's calculation of liquidation value, iRhythm Technologies's accounts receivable are only considered to be worth 75% of book value:

iRhythm Technologies's liquidation value for the quarter that ended in Mar. 2025 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=520.589-839.433+0.75 * 80.639+0.5 * 14.336
=-251.2

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


iRhythm Technologies Change In Receivables Related Terms

Thank you for viewing the detailed overview of iRhythm Technologies's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


iRhythm Technologies Business Description

Traded in Other Exchanges
Address
699 8th Street, Suite 600, San Francisco, CA, USA, 94103
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

iRhythm Technologies Headlines

No Headlines